Form 4: Edgewell Personal Care Chief Accounting Officer Acquires Restricted Stock Equivalents

Sentiment:

SEC Form 4 Filing


John M. Dunham, Chief Accounting Officer of Edgewell Personal Care, acquired 1,383 restricted stock equivalents on November 8, 2024.

Summary

  • John M. Dunham, the Chief Accounting Officer of Edgewell Personal Care, was granted 1,383 restricted stock equivalents (RSEs) on November 8, 2024.
  • These RSEs will vest and convert into shares of Edgewell common stock in three equal installments on November 8, 2025, November 8, 2026, and November 8, 2027, provided Mr. Dunham remains employed by the company on those dates.
  • The vesting of these RSEs may also occur upon death, disability, a change in control, or certain termination events.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. There are no negative implications.

Positives

  • The grant of restricted stock equivalents aligns the interests of the Chief Accounting Officer with the long-term performance of the company.
  • The vesting schedule encourages continued employment and commitment from the executive.

Risks

  • The vesting of the RSEs is contingent on continued employment, which could be a risk if the executive leaves the company before the vesting dates.

Future Outlook

The restricted stock equivalents will vest over the next three years, contingent on continued employment, aligning the executive's interests with the company's long-term performance.

Industry Context

The granting of restricted stock equivalents is a common practice in executive compensation, aligning management's interests with shareholder value and long-term company performance.

Comparison to Industry Standards

  • Many companies in the consumer goods sector use restricted stock units or equivalents as part of their executive compensation packages.
  • The vesting schedule of one-third per year over three years is a fairly standard approach to incentivize long-term commitment.
  • Companies like Procter & Gamble and Unilever also use similar equity-based compensation methods for their executives.

Stakeholder Impact

  • Shareholders may view this positively as it aligns executive interests with long-term company performance.
  • Employees may see this as a standard practice in executive compensation.

Key Dates

DateDescription
11/08/2024Date of the transaction where 1,383 restricted stock equivalents were granted.
11/08/2025First vesting date for one-third of the restricted stock equivalents.
11/08/2026Second vesting date for one-third of the restricted stock equivalents.
11/08/2027Final vesting date for the remaining one-third of the restricted stock equivalents.
11/12/2024Date the form was signed.

Keywords

restricted stock equivalents, RSE, Edgewell Personal Care, John M. Dunham, Chief Accounting Officer, stock options, executive compensation, vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.